Form 4 · Filed Jul 24, 2026, 01:22 AM UTC
ARTV/Artiva Biotherapeutics, Inc.
RA CAPITAL MANAGEMENT, L.P. — director
AI Thesis
A thesis has not been generated for this filing yet — usually available within 60 seconds of EDGAR publication. Refresh shortly.
Research signal, not investment advice. Form 4 AI surfaces SEC filings and applies an analytical layer — it does not predict prices or recommend trades. Past performance does not guarantee future results. See methodology and public track record for how scores are computed.
Transactions
3 rows| Date | Code | Direction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Jul 23, 2026 | P | buy | 59,880 | $10 | $596,405 | 17,242,483 |
| Jul 22, 2026 | P | buy | 84,124 | $10 | $835,351 | 17,182,603 |
| Jul 21, 2026 | P | buy | 120,582 | $10 | $1,151,558 | 17,098,479 |
Source: SEC EDGAR raw filing ↗ · Accession 0001231919-26-000791